Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by longterm56on Jun 14, 2020 8:09pm

122 Views

Post# 31149440

RE:RE:RE:RE:RE:RE:Thera career section

Not only that, but with his lengthy career at Pfizer, I'm sure he knows people that would be outstanding additions to Thera to fill these positions, and if he has a good enough story/plan he might be able to recruit them. This is getting exciting!

-LT

palinc2000 wrote: Paul is a problem solver and the carreer section jives perfectly with Paul's very first comment in the PR dated March 2 nd announcing his nomination as new CEO
"One of my main goals is to bring Trogarzo to people living with HIV ........"
I remember commenting at that time that the statement meant that in his mind the proper launch of Trogarzo had not yet occurred...
The former Ceo had 3 years to get this done so I hope the doubters give Paul more than 3 months to build that franchise